Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies

Abstract

We evaluated the performance of new enzyme immunoassay (EIA) kits (Pyloriset; Orion Corporation, Orion Diagnostica, Espoo, Finland) for the detection of immunoglobulin G (IgG) and IgA antibodies to Helicobacter pylori in serum. Serum samples from 195 patients with upper abdominal complaints were collected. Biopsy specimens of the gastric mucosae were taken for histological analysis and bacterial culture. The sensitivity, specificity, positive and negative predictive values, and efficacy of the Pyloriset EIA-G in detecting IgG antibodies to H. pylori were 92, 84, 88, 90, and 89%, respectively, when compared with those of the reference methods used. The corresponding data for detection of IgA antibodies were 80, 89, 89, 79, and 84%, respectively. The overall prevalence of defined H. pyloni positivity was 54%. Moreover, the antibody tests showed a very good correlation with the biopsy findings. IgG antibodies were found in 93% of sera from patients with documented gastritis and H. pylori positivity, whereas only 4% of the sera from patients with documented gastritis and H. pylori-negative patients was positive. The results obtained for IgA antibodies were 81 and 6%, respectively. We conclude that the Pyloriset EIA-G, the test for IgG antibodies, is a good and reliable test for the detection of antibodies to H. pylori and as an indication of H. pyloni infection. The determination of IgA antibodies may be used as a test that complements the IgG antibody assay.

What is the role of serology in assessing Helicobacter pylori eradication?

“…Two ELISA kits detecting specific IgG were used and one kit detecting IgA. These kits have been found suitable for screening patients with H. pylori infection 16–18 and have already been used for patient follow‐up 19 ,. 20 The main advantage of the EPI kits (HM‐CAP and PP‐CAP) is their convenience, since the incubation times are shorter, i.e.…”

Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection

“…A range of ages was represented in the group, such that the population as a whole was not composed primarily of older individuals, in whom a higher incidence of H. pylori infection and atrophic gastritis might be expected. It has been suggested that the presence of atrophic gastritis may result in a positive serology (as an indicator of ''inactive'' or past infection) with a negative biopsy or UBT result (9,13). Although the mean age of the UBT-positive group was slightly higher than the mean age of the UBT-negative group, the mean age of the group demonstrating false-positive G.A.P.…”

Does Helicobacter pylori Infection Increase Incidence of Dementia? The Personnes Agées QUID Study

“…A serological assay for H. pylori IgG antibodies was performed using an enzyme-linked immunosorbent assay (ELISA) (Pyloriset EIA-G kit, Orion Diagnostica, Espoo, Finland). 19 A positive result was defined as a titer of antibodies of 20 IU/mL or greater, according to the manufacturer's recommendations. The HELICO BLOT 2.1 (Genelabs Diagnostics, Singapore Science Park) was used for the detection of antibodies to specific proteins of H. pylori, including pathogenic factors (e.g., CagA), as previously described.…”